Acta Pharmaceutica Sinica B (Feb 2020)

PXR: a center of transcriptional regulation in cancer

  • Yaqi Xing,
  • Jiong Yan,
  • Yongdong Niu

Journal volume & issue
Vol. 10, no. 2
pp. 197 – 206

Abstract

Read online

Pregnane X receptor (PXR, NR1I2) is a prototypical member of the nuclear receptor superfamily. PXR can be activated by both endobiotics and xenobiotics. As a key xenobiotic receptor, the cellular function of PXR is mostly exerted by its binding to the regulatory gene sequences in a ligand-dependent manner. Classical downstream target genes of PXR participate in xenobiotic responses, such as detoxification, metabolism and inflammation. Emerging evidence also implicates PXR signaling in the processes of apoptosis, cell cycle arrest, proliferation, angiogenesis and oxidative stress, which are closely related to cancer. Here, we discussed, in addition to the characterization of PXR per se, the biological function and regulatory mechanism of PXR signaling in cancer, and its potential for the targeted prevention and therapeutics. Key words: PXR, NR1I2, PAR, Signaling, Nuclear receptor, Transcriptional regulation, Cancer